Healthcare

● Candel Therapeutics shares have fallen sharply, most recently closing at $12.35, down 8.52%, after rising on a Bank of America price-target raise to $12.00 from $9.00.

● Acrivon Therapeutics shares have fallen sharply, most recently closing at $2.20, down 7.95%, without a confirmed negative catalyst; the company's most recent releases had been constructive.

● Attovia Therapeutics shares have fallen sharply, most recently closing at $20.21, down 8.72%, after an upsized IPO priced at $17.00 per share, the high end of its range, for about $289 million in gross proceeds.

● ARS Pharmaceuticals shares have fallen sharply, most recently closing at $5.51, down 13.71%, with totalRevenueof $33.7 million and a net loss of $62.3 million, or $0.63 per share, in the recent quarter.

● China SXT Pharmaceuticals has fallen sharply, most recently closing at $3.63, down 20.04%, the latest swing in a stock whose float has been repeatedly reshaped by corporate actions.

● Tenon Medical shares have swung sharply following mixed Q2 results, most recently closing at $7.07, down 38.04%.

● Sionna Therapeutics shares have fallen sharply, most recently closing at $5.52, down 11.68%, after topline data from two development programs.